Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$21.00 Web:$18.90 add to cart Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles From Cancer Patient to Cancer Survivor: Lost in Transition The Learning Healthcare System: Workshop Summary (IOM Roundtable on Evidence-Based Medicine) Other Related Titles Medical Innovation in the Changing Healthcare Marketplace: Conference Summary (2002) Institute of Medicine (IOM) Board on Science, Technology, and Economic Policy (STEP) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 43   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendixes Page 43 Front Matter (R1-R12) Executive Summary (1-8) 1. Introduction (9-11) 2. The Characteristics of Medical Innovation (12-14) 3. The Costs and Benefits of Medical Innovation (15-24) 4. Cost-Effectiveness Studies: A Key to Innovation Development (25-33) 5. Barriers to Medical Innovation (34-42) Appendix A: Conference Agenda (43-49) Appendix B: Conference Participant List (50-56) Appendix C: Keynote Speech: Encouraging High-Value Medical Innovation, Mark McClellan, Council of Economic Advisers (57-64) Appendix D: Keynote Speech: Bridging the Quality Chasm, David Lawrence, Kaiser Permanente (65-80)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 43
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary Appendixes

OCR for page 44
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary This page in the original is blank.

OCR for page 45
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary A Conference Agenda The National Academies Board on Science, Technology, and Economic Policy Board on Health Care Services, Institute of Medicine Agenda Conference on Medical Innovation in the Changing Healthcare Marketplace June 14-15, 2001 National Academies Main Building 2100 C Street, NW, Washington, DC June 14 8:00 AM Continental Breakfast 8:30 AM Welcome and Introduction of Keynote Speaker Cochair: Ed Penhoet, UC Berkeley 8:35 AM Keynote Address—Encouraging High-Value Innovation: Medicare and Other Federal Policies Speaker: Mark McClellan, Council of Economic Advisers 9:15 AM Objectives for the Conference Cochairs: Ed Penhoet, UC Berkeley, and Kathy Behrens, RS Investments The cochairs will outline the background to and their goals for the conference.

OCR for page 46
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary 9:45 AM Report from an NAE Workshop on Engineering and Health Care Delivery Systems Speaker: Jerry Grossman, Kennedy School of Government, Harvard University 10:00 AM Panel I: The Macro Picture—Trends in Health Care Costs and Benefits This session will examine at the macro level the extent to which new medical technology is driving up health care costs and, the equally important issue of whether new medical technology is bringing more benefits. Moderator: Philip Aspden, NRC Panelists:   • Sheila Smith, CMS, formerly HCFA • Alison Keith, Pfizer, Inc. (ret.) • Kevin Murphy, University of Chicago 11:15 AM Break. 11:30 AM Panel IIA: Cardiovascular Disease—Trends in Health Care Costs and Benefits In this session the panelists will examine in more detail trends in the costs and benefits of new medical technology by considering cardiovascular disease. The long-term health care cost implications of successful treatment of cardiovascular disease will be considered. Moderator: David Gollaher, California Healthcare Institute Panelists:   • Elizabeth Nabel, NHLBI • Dan Mark, Duke University • Paul Citron, Medtronic • David Cutler, Harvard University 1:00 PM Lunch

OCR for page 47
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary 2:00 PM Panel IIB: Cardiovascular Disease—Fostering High-Value Medical Innovation Panelists will examine the barriers to innovation in the development, adoption, and diffusion of new treatments of cardiovascular disease. Ways to overcome identified barriers will also be considered. Moderator: Kathy Behrens, RS Investments Panelists:   • Tom Fogarty, Stanford University • Mark Hlatky, Stanford University • Laurel Sweeney, Philips Medical Systems 3:30 PM Break. 3:45 PM Panel IIIA: Metastatic Melanoma—Trends in Health Care Costs and Benefits In this session the panelists will examine in more detail trends in the costs and benefits of new medical technology by considering metastatic melanoma. The long-term health care cost implications of successful treatment of metastatic melanoma will be considered. Moderator: Gil Omenn, University of Michigan Panelists:   • Steven Rosenberg, National Cancer Institute • Mike Atkins, Beth Israel Deaconess Medical Center, Harvard Medical School • Margaret Tucker, National Cancer Institute • Bruce Hillner, Medical College of Virginia 5:30 PM Close 6:00 PM Reception * * * *

OCR for page 48
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary June 15 8:00 AM Continental Breakfast. 8:30 AM Welcome and Recap Cochairs: Ed Penhoet, UC Berkeley, and Kathy Behrens, RS Investments 8:45 AM Key Note Speaker Speaker: David Lawrence, Kaiser Permanente Dr. Lawrence will speak about the recent IOM report, Crossing the Quality Chasm, medical care in the 21st century, the drivers of innovation, and possible public policy levers to foster high-value medical innovation. 9:45 AM Panel IIIB: Metastatic Melanoma—Fostering High-Value Medical Innovation Panelists will examine the barriers to innovation in the development, adoption, and diffusion of new treatments of metastatic melanoma. Ways to overcome identified barriers will also be considered. Moderator: Ed Penhoet, UC Berkeley Panelists:   • Bruce Scharschmidt, Chiron • Richard Pazdur, FDA • Robert Young, Fox Chase Cancer Center • Jonathan Lewis, Antigenics 11:00 AM Break. 11:15 AM Panel IV: The Macro Picture—Fostering High-Value Medical Innovation In this session panelists will examine public policy initiatives at the macro level that will foster the development, adoption, and diffusion of high-value medical innovation.

OCR for page 49
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary Moderator: Alan Garber, Stanford University Panelists:   • Susan Bartlett Foote, University of Minnesota • Sean Tunis, CMS, formerly HCFA • Jamie Robinson, UC Berkeley 1:00 PM Lunch 1:30 PM Panel IV (cont.): The Macro Picture—Fostering High-Value Medical Innovation Panelists:   • Brandon Hull, Cardinal Partners • Fran Visco, National Breast Cancer Coalition • John Ford, House Committee on Energy and Commerce/ Democratic Staff 2:45 PM Session VI: Wrap-up Discussion The final session will allow participants to discuss the key issues arising from the conference. Moderators: Cochairs: Ed Penhoet, UC Berkeley, Kathy Behrens, RS Investments.

Representative terms from entire chapter:

medical technology